leadf
logo-loader
viewVolitionRx

VolitionRX hosts Capital Markets Day at the NYSE

VolitionRx (NYSE AMERICAN:VNRX) CEO Cameron Reynolds tells Proactive Investors the life sciences company has organized a Capital Markets Day to bring together shareholders, company executives and analysts at the New York Stock Exchange.

The company plans to offer updates of results, ongoing projects and of plans for potential new paths to revenue, including trials in diagnosing lung cancer.

Quick facts: VolitionRx

Price: 3.04 USD

NYSEMKT:VNRX
Market: NYSEMKT
Market Cap: $145.68 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of VolitionRx named herein, including the promotion by the Company of VolitionRx in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

VolitionRX progressing towards launch of first commercial products using...

VolitionRx Limited's (NYSEAMERICAN:VNRX) Cameron Reynolds tells Proactive the firm rounded out the second quarter with $21.3 million in cash and equivalents compared to $12 million in the same quarter a year ago. The company's now tested two independent cohorts of COVID-19 positive patients with...

on 08/14/2020

2 min read